Telling a Story that Drives Investment

Trevor Loy

Trevor Loy, Partner, Flywheel Ventures

When presenting an opportunity to investors, entrepreneurs usually begin by describing their invention and explaining why people need it. Next they present the financial team’s projections about what customers would probably pay for the product or service and what the entrepreneurs want to charge. They end by introducing the entrepreneurial team and detailing members’ credentials.

This approach is the inverse of what venture capitalists like me care about and consider when evaluating an investment. I want to hear about a venture the way I want to read a book or watch a movie: I want a story. Who are the protagonists and the other main characters? What goals do the characters hope to achieve, and how valuable would the goal be if it’s reached? What challenges do the characters anticipate and how will they respond to them? Finally I want to know my role so I can decide if I want the part.

Continue reading

Federal Funding Still Good for Small Technology Firms

 

Jim and Gail Greenwood

Jim and Gail Greenwood for NNM Connect and TVC

Congress in December voted to continue two federal programs that offer funding to small businesses involved in technology and innovation. The Small Business Innovation Research Program (SBIR) and the Small Business Technology Transfer Program (STTR) were reauthorized as part of the National Defense Authorization Act, ensuring their funding through 2017.

Continue reading

Fund Accelerates Product Commercialization

Monica Abeita

Monica Abeita, Regional Development Corp. for NNM Connect

A $100,000 award from the Venture Acceleration Fund in 2011 helped Santa Fe startup Vista Therapeutics speed up the commercial introduction of the NanoBioSensor, which employs nanowires to measure in real time the multiple blood proteins and other biomarkers the body produces in response to trauma or disease. Biomarker measurement is especially critical for emergency room doctors, who have little time to gauge the severity of a patient’s condition and choose a proper intervention. Benefits continue during recovery, when ongoing monitoring is essential.

As the first commercially available device capable of such on-the-spot analysis, the NanoBioSensor is expected to improve the lives of people and also reduce the suffering of research animals: Pharmaceutical scientists and other biomedical researchers often must sacrifice many animals to obtain sufficient blood or tissue samples for analysis of biomarker changes over time. The sensitivity and rapidity of Vista’s sensor will allow many biomarkers to be monitored with a simple nick of the research animal’s tail or ear.

Continue reading

Venture Capitalists Put Market Before Product

Trevor Loy

Trevor Loy, Partner, Flywheel Ventures

When searching for investors, many entrepreneurs and inventors first present their product or technological innovation and then vaguely present the target market as “people who need this product.” But this isn’t how customers think when deciding whether to spend money.

Consumers start with a problem or “pain point” they desperately want to go away. They watch for anything that proposes to solve this problem. Discovering it, they decide whether it’s affordable or whether another product offers a better or cheaper solution. They might even decide they’re willing to live with the inconvenience if the solution is too costly.

Continue reading

Investors Bring Benefits Beyond Capital

 

Les Mathews

Les Mathews, Mesa Capital Partners

Business owners who obtain outside equity – whether from family, friends or institutional investors – quickly learn money has strings attached.

Most outside equity providers want to get repaid over a reasonable period of time and at a very good rate of return. In exchange for providing capital, they obtain a piece of the company, thereby becoming business partners.

Continue reading

Looking for Equity? Seek the Right Specialist

Tom Stephenson

Tom Stephenson, Managing General Partner, Verge Fund

Specialization is common within the equity investment world, with investors generally focused on specific stages of business development. A “seed” stage investor, for example, has a different specialty than a firm that provides expansion capital.

An entrepreneur who knows the terms used to describe development-related types of equity financing is more likely to seek the investor right for her venture and increase the chance of obtaining funds.

Most investor specialization terms fall close to the following:

Seed-stage venture capital refers to investments made in firms with products under development or recently introduced to the market. Continue reading

Loans for Legacy, Equity for Growth

Tom Stephenson

Tom Stephenson, Managing General Partner, Verge Fund

Anyone looking for a business investor must examine their personal goals before looking for funding – different reasons for starting a business mean different ways of finding money.

Venture capitalists classify entrepreneurial businesses into two groups: growth businesses and lifestyle, or legacy, businesses. Only growth businesses will be attractive to venture-capital firms.

Lifestyle businesses are those started by people who want to have control over what they do and how they spend their time. These businesses tend to be focused on a local market, and entrepreneurs expect to own and run the business indefinitely. Continue reading